Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

239 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Rossouw JE, et al. Among authors: beresford sa. JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321. JAMA. 2002. PMID: 12117397 Clinical Trial.
Calcium plus vitamin D supplementation and the risk of fractures.
Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women's Health Initiative Investigators. Jackson RD, et al. Among authors: beresford sa. N Engl J Med. 2006 Feb 16;354(7):669-83. doi: 10.1056/NEJMoa055218. N Engl J Med. 2006. PMID: 16481635 Clinical Trial.
Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
Beresford SA, Weiss NS, Voigt LF, McKnight B. Beresford SA, et al. Lancet. 1997 Feb 15;349(9050):458-61. doi: 10.1016/S0140-6736(96)07365-5. Lancet. 1997. PMID: 9040575
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.
Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SA, Pettinger M, Lane DS, Lessin L, Yasmeen S, Singh B, Khandekar J, Shikany JM, Satterfield S, Chlebowski RT. Prentice RL, et al. Among authors: beresford sa. J Natl Cancer Inst. 2007 Oct 17;99(20):1534-43. doi: 10.1093/jnci/djm159. Epub 2007 Oct 9. J Natl Cancer Inst. 2007. PMID: 17925539 Free PMC article. Clinical Trial.
Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative.
Drieling RL, LaCroix AZ, Beresford SA, Boudreau DM, Kooperberg C, Chlebowski RT, Gass M, Crandall CJ, Womack CR, Heckbert SR. Drieling RL, et al. Among authors: beresford sa. Menopause. 2016 Nov;23(11):1168-1175. doi: 10.1097/GME.0000000000000696. Menopause. 2016. PMID: 27433859 Free PMC article.
Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer.
Phipps AI, Doherty JA, Voigt LF, Hill DA, Beresford SA, Rossing MA, Chen C, Weiss NS. Phipps AI, et al. Among authors: beresford sa. Cancer Causes Control. 2011 Dec;22(12):1639-46. doi: 10.1007/s10552-011-9840-6. Epub 2011 Sep 11. Cancer Causes Control. 2011. PMID: 21909949 Free PMC article.
Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study.
Prentice RL, Pettinger M, Beresford SA, Wactawski-Wende J, Hubbell FA, Stefanick ML, Chlebowski RT. Prentice RL, et al. Among authors: beresford sa. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1531-7. doi: 10.1158/1055-9965.EPI-08-1209. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19423530 Free PMC article. Clinical Trial.
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML; WHI Investigators. Heiss G, et al. Among authors: beresford sa. JAMA. 2008 Mar 5;299(9):1036-45. doi: 10.1001/jama.299.9.1036. JAMA. 2008. PMID: 18319414 Clinical Trial.
Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
Chubak J, Doherty JA, Cushing-Haugen KL, Voigt LF, Saltzman BS, Hill DA, Beresford SA, Weiss NS. Chubak J, et al. Among authors: beresford sa. Cancer Causes Control. 2007 Nov;18(9):1001-7. doi: 10.1007/s10552-007-9040-6. Epub 2007 Jul 25. Cancer Causes Control. 2007. PMID: 17653829
Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer.
Reed SD, Voigt LF, Beresford SA, Hill DA, Doherty JA, Weiss NS. Reed SD, et al. Among authors: beresford sa. Am J Obstet Gynecol. 2004 Oct;191(4):1146-51. doi: 10.1016/j.ajog.2004.04.041. Am J Obstet Gynecol. 2004. PMID: 15507934
239 results
Jump to page
Feedback